2 results
Approved WMORecruiting
To assess the effects and costs of the use of the Australian Medical Sheepskin and usual care with regard to the prevention of sacral pressure ulcers in somatic nursing home clients, versus usual care only.
Approved WMORecruiting
Primary(Part I and Part II):- To determine the maximum tolerated dose (MTD) and/or recommended Phase 2 dose (RP2D) in the QW and/or Q3W regimens of RO7122290 in combination with cibisatamab after pretreatment with obinutuzumab- To characterize theā¦